.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Moodys
Cipla
Baxter
Fish and Richardson
AstraZeneca
Deloitte
Cerilliant
Federal Trade Commission
Daiichi Sankyo

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,983,743

« Back to Dashboard

Which drugs does patent 6,983,743 protect, and when does it expire?


Patent 6,983,743 protects ATROVENT HFA and is included in one NDA.

This patent has forty-six patent family members in thirty-seven countries.

Summary for Patent: 6,983,743

Title:Stainless steel canister for propellant-driven metering aerosols
Abstract:The present invention relates to corrosion resistant stainless steel canisters for propellant-containing aerosol formulations for use in propellant gas-operated inhalers.
Inventor(s): Hoelz; Hubert (Oberheimbach, DE), Lostritto; Richard Thomas (Gaithersburg, MD), Nagel; Juergen (Bad Kreuznach, DE), Vega; Julio Ce (Capital Federal Buenos Aires, AR)
Assignee: Boehringer Ingelheim Pharma KG (Ingelheim, DE)
Application Number:10/849,725
Patent Claim Types:
see list of patent claims
Delivery; Device; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 2004RXYesYes6,983,743► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 6,983,743

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,739,333 Stainless steel canister for propellant-driven metering aerosols► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,983,743

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan4048027► Subscribe
Hungary224648► Subscribe
Israel146713► Subscribe
Poland205866► Subscribe
Poland352052► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Medtronic
Queensland Health
Cerilliant
Colorcon
Accenture
Julphar
Novartis
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot